Colorectal Cancer Rates Decline in Older Adults While Rising Among Younger Groups
Similar Articles
Colorectal Cancer Now Leading Cancer Killer Among Adults Under 50
New Breast Cancer Screening Guidelines Emphasize Risk-Based Approach
Australia on Track to Eliminate Cervical Cancer by 2035
New Drugs Target 'Zombie' Cells to Combat Cancer and Aging
Pre-Surgery Immunotherapy Shows Promise for a Subtype of Colorectal Cancer
A major Swiss study shows colorectal cancer rates are falling among adults aged 50 to 74, likely due to increased screening. However, diagnoses are rising in adults under 50, with nearly 28% of younger patients presenting with metastatic disease at diagnosis. The findings highlight a shifting demographic for a cancer that remains a leading cause of death worldwide.
Facts First
- Colorectal cancer rates are falling in adults aged 50–74, dropping 1.7% per year in men and 2.8% in women.
- Diagnoses are rising in adults under 50, increasing by about 0.5% per year and accounting for 6.1% of cases.
- Younger patients are more likely to have metastatic disease at diagnosis (28%) compared to older patients (20%).
- The increase in younger adults primarily involves rectal cancers in both sexes and right-sided colon cancers in young women.
- Colorectal cancer is the third most common cancer globally, with over 1.9 million new cases and nearly 900,000 deaths reported in 2022.
What Happened
A nationwide Swiss study analyzed nearly 100,000 colorectal cancer cases diagnosed between 1980 and 2021. The research, led by scientists from the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG), found divergent trends: incidence rates dropped significantly in adults aged 50 to 74, while they rose by approximately 0.5% per year among adults under 50. The study, published in the European Journal of Cancer, also found that younger patients were more likely to have metastatic disease at diagnosis.
Why this Matters to You
If you are under 50, you may be part of a demographic seeing a rising incidence of colorectal cancer. This means being aware of symptoms like persistent abdominal pain, blood in the stool, unexplained weight loss, or lasting changes in bowel habits could be increasingly important for your health. For those over 50, the declining rates suggest that existing screening programs are effective, and continuing to participate in them is beneficial. The study's finding that younger patients often present with more advanced disease underscores the potential value of earlier detection and awareness.
What's Next
The trend observed in Switzerland may prompt further review of screening guidelines globally. The United States has already lowered the recommended screening starting age to 45. Other countries with high rates of colorectal cancer, like those in Europe, Australia, and New Zealand, may consider similar adjustments. Public health efforts are likely to focus on raising awareness of symptoms among younger adults and investigating the causes behind the rising incidence in this group.